{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:04Z","timestamp":1792155724251,"version":"4.4.0"},"reference-count":118,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17\u201319 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF.<\/jats:p>","DOI":"10.1093\/europace\/eux318","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T07:05:50Z","timestamp":1514876750000},"page":"395-407","source":"Crossref","is-referenced-by-count":105,"title":["Integrating new approaches to atrial fibrillation management: the 6th AFNET\/EHRA Consensus Conference"],"prefix":"10.1093","volume":"20","author":[{"given":"Dipak","family":"Kotecha","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Breithardt","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"},{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A John","family":"Camm","sequence":"additional","affiliation":[{"name":"St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schotten","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"School for Cardiovascular Diseases, Maastricht University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ahlsson","sequence":"additional","affiliation":[{"name":"Orebro University Hospital, Orebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arnar","sequence":"additional","affiliation":[{"name":"The National University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[{"name":"Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Auricchio","sequence":"additional","affiliation":[{"name":"Fondazione Cardiocentro Ticino, Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Bax","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Benussi","sequence":"additional","affiliation":[{"name":"University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Blomstrom-Lundqvist","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institution of Medical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[{"name":"University of Mannheim, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"DIMES Department, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Brandes","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[{"name":"The Johns Hopkins Hospital, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Casadei","sequence":"additional","affiliation":[{"name":"Oxford University, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Castell\u00e1","sequence":"additional","affiliation":[{"name":"Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Chua","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Crijns","sequence":"additional","affiliation":[{"name":"University Hospital Maastricht, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[{"name":"University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Fabritz","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK"},{"name":"University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Feuring","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co. KG, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Freedman","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gerth","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"St Vincenz Krankenhaus, Paderborn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Guasch","sequence":"additional","affiliation":[{"name":"Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Haase","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Hatem","sequence":"additional","affiliation":[{"name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Georg","family":"Haeusler","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[{"name":"Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hendriks","sequence":"additional","affiliation":[{"name":"University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Hunter","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co. KG, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00e4\u00e4b","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians University Clinic, Munich, Germany & DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kespohl","sequence":"additional","affiliation":[{"name":"Bayer HealthCare AG, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"HaeuslerCharit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre A","family":"Lane","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lewalter","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"Hospital-Munich Thalkirchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Mont","sequence":"additional","affiliation":[{"name":"Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nabauer","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens C","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oeff","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"St\u00e4dtisches Klinikum Brandenburg, Brandenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Oldgren","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institution of Medical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Oto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pison","sequence":"additional","affiliation":[{"name":"Maastricht University, Medical Center, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, Clinical Centre of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Ravens","sequence":"additional","affiliation":[{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"},{"name":"University Heart Center Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Richard-Lordereau","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Savelieva","sequence":"additional","affiliation":[{"name":"St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Schnabel","sequence":"additional","affiliation":[{"name":"University Heart Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz F","family":"Sinner","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians University Clinic, Munich, Germany & DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Sommer","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig, University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakis","family":"Themistoclakis","sequence":"additional","affiliation":[{"name":"Ospedale dell\u2019Angelo, Mestre-Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C","family":"Van Gelder","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis E","family":"Vardas","sequence":"additional","affiliation":[{"name":"Heraklion University Hospital, Heraklion, Crete, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Verma","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Southlake Regional Health Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Wakili","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Weber","sequence":"additional","affiliation":[{"name":"Bayer HealthCare AG, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Werring","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[{"name":"University Heart Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Roche Diagnostics International Ltd, Rotkreuz, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig, University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK"},{"name":"Department of Cardiovascular Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"},{"name":"Atrial Fibrillation NETwork (AFNET), M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"2026080923263914500_eux318-B1","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B2","doi-asserted-by":"crossref","first-page":"e005155.","DOI":"10.1161\/JAHA.116.005155","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care","volume":"6","author":"Lane","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026080923263914500_eux318-B3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B4","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.194","article-title":"Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment","volume":"13","author":"Fabritz","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026080923263914500_eux318-B6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/europace\/euv304","article-title":"A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network\/European Heart Rhythm Association consensus conference","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B7","first-page":"130","article-title":"Is pulse palpation helpful in detecting atrial fibrillation? A systematic review","volume":"55","author":"Cooke","year":"2006","journal-title":"J Fam Pract"},{"key":"2026080923263914500_eux318-B8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3399\/bjgp11X548956","article-title":"Screening for atrial fibrillation: sensitivity and specificity of a new methodology","volume":"61","author":"Lewis","year":"2011","journal-title":"Br J Gen Pract"},{"key":"2026080923263914500_eux318-B9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jce.12842","article-title":"PULSESMART: pulse-based arrhythmia discrimination using a novel smartphone application","volume":"27","author":"McManus","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923263914500_eux318-B10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12325-011-0087-0","article-title":"Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients","volume":"29","author":"Marazzi","year":"2012","journal-title":"Adv Therapy"},{"key":"2026080923263914500_eux318-B11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.amjcard.2014.07.016","article-title":"Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation","volume":"114","author":"Wiesel","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026080923263914500_eux318-B12","doi-asserted-by":"crossref","first-page":"e004565.","DOI":"10.1136\/bmjopen-2013-004565","article-title":"Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors","volume":"4","author":"Kearley","year":"2014","journal-title":"BMJ Open"},{"key":"2026080923263914500_eux318-B13","doi-asserted-by":"crossref","first-page":"S205.","DOI":"10.1016\/j.hlc.2013.05.488","article-title":"Performance of an automated iPhone ECG algorithm to diagnose atrial fibrillation in a community AF screening program (SEARCH-AF)","volume":"22","author":"Lau","year":"2013","journal-title":"Heart Lung Circ"},{"key":"2026080923263914500_eux318-B14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/europace\/euu057","article-title":"Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation","volume":"16","author":"Tieleman","year":"2014","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2296-15-113","article-title":"The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care","volume":"15","author":"Vaes","year":"2014","journal-title":"BMC Family Practice"},{"key":"2026080923263914500_eux318-B16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14017430802593435","article-title":"Short-term ECG for out of hospital detection of silent atrial fibrillation episodes","volume":"43","author":"Doliwa","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"2026080923263914500_eux318-B17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration","volume":"135","author":"Freedman","year":"2017","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/europace\/euw279","article-title":"Atrial high-rate episodes and stroke prevention","volume":"19","author":"Camm","year":"2017","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","article-title":"Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial","volume":"25","author":"Fetsch","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2010.06.042","article-title":"Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)","volume":"160","author":"Ruff","year":"2010","journal-title":"Am Heart J"},{"key":"2026080923263914500_eux318-B24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ehj.2004.06.014","article-title":"Suppression of paroxysmal atrial tachyarrhythmias\u2013results of the SOPAT trial","volume":"25","author":"Patten","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1160\/TH11-02-0070","article-title":"Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions","volume":"105","author":"Kirchhof","year":"2011","journal-title":"Thromb Haemost"},{"key":"2026080923263914500_eux318-B26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2012.10.010","article-title":"Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: the retrospective evaluation and assessment of therapies in AF (TREAT-AF) study","volume":"165","author":"Turakhia","year":"2013","journal-title":"Am Heart J"},{"key":"2026080923263914500_eux318-B27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2026080923263914500_eux318-B28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/europace\/eup124","article-title":"Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET\/EHRA consensus conference on atrial fibrillation entitled \u2018research perspectives in atrial fibrillation\u2019","volume":"11","author":"Kirchhof","year":"2009","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B29","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation: the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/eurjhf\/hft004","article-title":"Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade atrial fibrillation Study","volume":"15","author":"Potpara","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080923263914500_eux318-B31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.5167","article-title":"The role of cardiovascular implantable electronic devices in the detection and treatment of subclinical atrial fibrillation: a review","volume":"2","author":"Hess","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026080923263914500_eux318-B32","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of\u2009&gt;\u200910, 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B35","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B36","volume-title":"Integrated Care Better and Cheaper","author":"Schrijvers","year":"2016"},{"key":"2026080923263914500_eux318-B37","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B38","doi-asserted-by":"crossref","first-page":"e002950","DOI":"10.1161\/JAHA.115.002950","article-title":"An integrated management approach to atrial fibrillation","volume":"5","author":"Carter","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026080923263914500_eux318-B39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/europace\/eut055","article-title":"Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation","volume":"15","author":"Hendriks","year":"2013","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B40","article-title":"European Society of Cardiology (ESC) smartphone and tablet applications for patients with atrial fibrillation and their healthcare providers","author":"Kotecha","year":"2017","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00001888-200601000-00009","article-title":"The physician-hospital team: a successful approach to improving care in a large academic medical center","volume":"81","author":"Feldman","year":"2006","journal-title":"Acad Med"},{"key":"2026080923263914500_eux318-B42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/clinchem.2016.255182","article-title":"Application of biomarkers for risk stratification in patients with atrial fibrillation","volume":"63","author":"Hijazi","year":"2017","journal-title":"Clin Chem"},{"key":"2026080923263914500_eux318-B43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2026080923263914500_eux318-B44","doi-asserted-by":"crossref","first-page":"e000250.","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026080923263914500_eux318-B45","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/eurheartj\/ehw077","article-title":"Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation","volume":"37","author":"Aspberg","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B46","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B47","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.116.022802","article-title":"Performance and validation of a novel biomarker-based stroke risk score for atrial fibrillation","volume":"134","author":"Oldgren","year":"2016","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B48","first-page":"3258","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O\u2019Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B49","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"2026080923263914500_eux318-B50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamacardio.2016.3311","article-title":"Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: a subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"1","author":"Ruff","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080923263914500_eux318-B51","first-page":"888","article-title":"A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"38","author":"Fanola","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923263914500_eux318-B53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923263914500_eux318-B54","doi-asserted-by":"crossref","first-page":"e004549.","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026080923263914500_eux318-B55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"2026080923263914500_eux318-B56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hrthm.2014.02.003","article-title":"Very long-term outcome after initially successful catheter ablation of atrial fibrillation","volume":"11","author":"Steinberg","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080923263914500_eux318-B57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923263914500_eux318-B58","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B59","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.hrthm.2017.02.001","article-title":"Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: a propensity score-matched analysis","volume":"14","author":"Saliba","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026080923263914500_eux318-B60","doi-asserted-by":"crossref","first-page":"h4451.","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"2026080923263914500_eux318-B61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jamacardio.2016.2193","article-title":"Exploring the potential benefits and risks of anticoagulation for atrial fibrillation during hospitalization for sepsis","volume":"1","author":"Fonarow","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080923263914500_eux318-B62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080923263914500_eux318-B63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ahj.2013.12.010","article-title":"New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft","volume":"167","author":"Lee","year":"2014","journal-title":"Am Heart J"},{"key":"2026080923263914500_eux318-B64","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.114.014058","article-title":"Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study","volume":"131","author":"Lubitz","year":"2015","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B65","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1161\/STROKEAHA.114.006202","article-title":"Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage","volume":"45","author":"Pasquini","year":"2014","journal-title":"Stroke"},{"key":"2026080923263914500_eux318-B66","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"2026080923263914500_eux318-B67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","article-title":"Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study","volume":"132","author":"Nielsen","year":"2015","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM200001273420403","article-title":"Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage","volume":"342","author":"O\u2019Donnell","year":"2000","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B69","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/heartjnl-2013-305151","article-title":"Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives","volume":"100","author":"Haeusler","year":"2014","journal-title":"Heart"},{"key":"2026080923263914500_eux318-B70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B71","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"2026080923263914500_eux318-B72","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B73","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis","volume":"65","author":"Holmes","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B74","doi-asserted-by":"crossref","first-page":"e015099.","DOI":"10.1136\/bmjopen-2016-015099","article-title":"A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial","volume":"7","author":"Kotecha","year":"2017","journal-title":"BMJ Open"},{"key":"2026080923263914500_eux318-B75","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"2026080923263914500_eux318-B76","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B77","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2026080923263914500_eux318-B78","doi-asserted-by":"crossref","first-page":"i1855.","DOI":"10.1136\/bmj.i1855","article-title":"Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"key":"2026080923263914500_eux318-B79","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/eurjhf\/hfr046","article-title":"Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy","volume":"13","author":"Boriani","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080923263914500_eux318-B80","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","article-title":"Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure","volume":"69","author":"Kotecha","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B81","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.jacc.2016.08.048","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins","volume":"68","author":"Kotecha","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B82","first-page":"3250","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B83","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship","volume":"69","author":"Goudis","year":"2017","journal-title":"J Cardiol"},{"key":"2026080923263914500_eux318-B84","doi-asserted-by":"crossref","first-page":"e0165790.","DOI":"10.1371\/journal.pone.0165790","article-title":"Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties","volume":"11","author":"Kotecha","year":"2016","journal-title":"PLoS One"},{"key":"2026080923263914500_eux318-B85","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/europace\/eux027","article-title":"Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review","volume":"19","author":"Kotecha","year":"2017","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B86","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(12)60570-4","article-title":"Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial","volume":"380","author":"Kirchhof","year":"2012","journal-title":"Lancet"},{"key":"2026080923263914500_eux318-B87","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B88","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080923263914500_eux318-B89","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/europace\/euw262","article-title":"Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies","volume":"19","author":"Buiatti","year":"2017","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B90","doi-asserted-by":"crossref","first-page":"e003337.","DOI":"10.1161\/CIRCEP.115.003337","article-title":"Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-german atrial fibrillation competence network 1 trial","volume":"9","author":"Kuck","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923263914500_eux318-B91","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/eurheartj\/ehu354","article-title":"Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)","volume":"35","author":"Darkner","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B92","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/eht096","article-title":"A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice","volume":"34","author":"Berti","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B93","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2016.07.766","article-title":"PITX2 modulates atrial membrane potential and the antiarrhythmic effects of sodium-channel blockers","volume":"68","author":"Syeda","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B94","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/CIRCULATIONAHA.116.022931","article-title":"Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation","volume":"134","author":"Wijesurendra","year":"2016","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B95","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"2026080923263914500_eux318-B96","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2013.03.052","article-title":"Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation","volume":"62","author":"Fein","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B97","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00392-015-0856-x","article-title":"The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation","volume":"104","author":"Kornej","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2026080923263914500_eux318-B98","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026080923263914500_eux318-B99","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/europace\/eux163","article-title":"European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"2026080923263914500_eux318-B101","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2013.10.055","article-title":"Left atrial size and function: role in prognosis","volume":"63","author":"Hoit","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263914500_eux318-B102","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","article-title":"Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles","volume":"30","author":"Goette","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B103","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.hrthm.2016.01.004","article-title":"Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation","volume":"13","author":"Lankveld","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026080923263914500_eux318-B104","doi-asserted-by":"crossref","first-page":"e003354.","DOI":"10.1161\/CIRCEP.115.003354","article-title":"Atrial fibrillation complexity parameters derived from surface ecgs predict procedural outcome and long-term follow-up of stepwise catheter ablation for atrial fibrillation","volume":"9","author":"Lankveld","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923263914500_eux318-B105","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ehjci\/jev354","article-title":"EACVI\/EHRA expert consensus document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation","volume":"17","author":"Donal","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080923263914500_eux318-B107","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eur002","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B108","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehq005","article-title":"Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation","volume":"31","author":"Tops","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080923263914500_eux318-B109","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1136\/hrt.2010.215335","article-title":"Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation","volume":"97","author":"den Uijl","year":"2011","journal-title":"Heart"},{"key":"2026080923263914500_eux318-B110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"},{"key":"2026080923263914500_eux318-B111","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurjhf\/hfq126","article-title":"Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure","volume":"12","author":"Bertini","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026080923263914500_eux318-B112","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/europace\/eur186","article-title":"Prognostic value of total atrial conduction time estimated with tissue Doppler imaging to predict the recurrence of atrial fibrillation after radiofrequency catheter ablation","volume":"13","author":"den Uijl","year":"2011","journal-title":"Europace"},{"key":"2026080923263914500_eux318-B113","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal","volume":"91","author":"Schotten","year":"2011","journal-title":"Physiol Rev"},{"key":"2026080923263914500_eux318-B114","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.amjcard.2008.05.048","article-title":"Comparison of left atrial volumes and function by real-time three-dimensional echocardiography in patients having catheter ablation for atrial fibrillation with persistence of sinus rhythm versus recurrent atrial fibrillation three months later","volume":"102","author":"Marsan","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080923263914500_eux318-B115","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.echo.2014.08.017","article-title":"Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation","volume":"27","author":"Motoki","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080923263914500_eux318-B116","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.carpath.2013.12.001","article-title":"Atrial fibrillation from the pathologist\u2019s perspective","volume":"23","author":"Corradi","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"2026080923263914500_eux318-B117","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ncpcardio1370","article-title":"Structural remodeling in atrial fibrillation","volume":"5","author":"Corradi","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2026080923263914500_eux318-B118","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.hrthm.2005.06.026","article-title":"Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function","volume":"2","author":"Lemola","year":"2005","journal-title":"Heart Rhythm"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/20\/3\/395\/70576655\/europace_20_3_395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/20\/3\/395\/70576655\/europace_20_3_395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:37:14Z","timestamp":1786333034000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/3\/395\/4782691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eux318","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2018,1,2]]}}}